Alleviant Medical (Austin, Texas) has received FDA breakthrough device designation for its no-implant, interatrial shunt technology for treating certain types of chronic heart failure.
Founded in 2017, Alleviant’s minimally invasive transcatheter tech decompresses the left atrium without a permanent cardiac implant or open-heart surgery. Alleviant developed the teach to treat people who have heart failure with preserved (HFpEF) and mid-range ejection fraction (HFmrEF) — and remain symptomatic despite optimal guideline-directed medical therapy.
Get the full story on our sister site Medical Tubing + Extrusion.
